Insider holders · CIK 0001711279
Krystal Biotech, Inc. · KRYS
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Krish S KrishnanPresident and CEO | 1,347,543 | 50,000 | 1,397,543 | Sep 4, 2026 · 7:14 pm EDT | Form 4 |
| Suma KrishnanPresident, R&D | 1,302,145 | 50,000 | 1,352,145 | Sep 4, 2026 · 7:15 pm EDT | Form 4 |
| Daniel JanneyDirector | — | 455,046 | 455,046 | Sep 25, 2017 · 5:28 pm EDT | Form 4 |
| Dino A RossiDirector | 50,000 | — | 50,000 | Aug 14, 2026 · 6:22 pm EDT | Form 4 |
| R Douglas NorbyDirector | 9,000 | — | 9,000 | May 11, 2018 · 4:27 pm EDT | Form 4 |
| Antony A RileyChief Financial Officer | 2,800 | — | 2,800 | May 24, 2018 · 5:28 pm EDT | Form 4 |
| John Charles ThomasEVP, General Counsel | 0 | — | 0 | Jun 26, 2026 · 6:45 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.